Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Compounded retatrutide is a separate category and the FDA has issued public statements warning about online sellers using research-use labels
GI side effects nearly doubled when participants jumped straight to higher doses instead of titrating from the lowest starting dose
Proper disposal of unusable GLP-1 medications is important for safety and environmental protection
Confirm shipping logistics and cold chain requirements
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors currently in Phase 3 trials with no global regulatory approval
GLP-1 activation also slows gastric emptying, which means food stays in the stomach longer after eating
US$ 25.95
US$ 25.05
US$ 23.90
US$ 22.48
US$ 24.77
US$ 22.99
US$ 25.06
